Preventive cardiologyAbstractEffect of Different Antilipidemic Agents and Diets on Mortality. A Systematic Review

Hallvard Holdaas, Bengt Fellström, Alan G Jardine, Ingar Holme, Gudrun Nyberg, Per Fauchald, Carola Grönhagen-Riska, Søren Madsen, Hans-Hellmut Neumayer, Edward Cole, Bart Maes, Patrice Ambuhl, Anders G Olsson, Anders Hartmann, Dag O Solbu, Terje R Pedersen, Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial The Lancet. ,vol. 361, pp. 2024- 2031 ,(2003) , 10.1016/S0140-6736(03)13638-0

P Serruys, A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty Final results of the fluvastatin angiographic restenosis (FLARE) trial European Heart Journal. ,vol. 20, pp. 58- 69 ,(1999) , 10.1053/EUHJ.1998.1150

Gregory G. Schwartz, Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. ,vol. 285, pp. 1711- 1718 ,(2001) , 10.1001/JAMA.285.13.1711

A Kleemann, Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). European Heart Journal. ,vol. 20, pp. 1393- 1406 ,(1999) , 10.1053/EUHJ.1999.1483

Koon K. Teo, Jeffrey R. Burton, Christopher E. Buller, Sylvain Plante, Diane Catellier, Wayne Tymchak, Vladimir Dzavik, Dylan Taylor, Shinji Yokoyama, Terrence J. Montague, Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) Circulation. ,vol. 102, pp. 1748- 1754 ,(2000) , 10.1161/01.CIR.102.15.1748

J. Marmorston, F. J. Moore, C. E. Hopkins, O. T. Kuzma, J. Weiner, Clinical Studies of Long-Term Estrogen Therapy in Men with Myocardial Infarction Experimental Biology and Medicine. ,vol. 110, pp. 400- 408 ,(1962) , 10.3181/00379727-110-27531

Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moye, Jean L. Rouleau, John D. Rutherford, Thomas G. Cole, Lisa Brown, J. Wayne Warnica, J. Malcolm O. Arnold, Chuan-Chuan Wun, Barry R. Davis, Eugene Braunwald, The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels The New England Journal of Medicine. ,vol. 335, pp. 1001- 1009 ,(1996) , 10.1056/NEJM199610033351401

Homer S Black, J Alan Herd, Leonard H Goldberg, John E Wolf Jr, John I Thornby, Theodore Rosen, Suzanne Bruce, Jaime A Tschen, John P Foreyt, Lynne W Scott, Suzanne Jaax, Kelly Andrews, None, Effect of a Low-Fat Diet on the Incidence of Actinic Keratosis The New England Journal of Medicine. ,vol. 330, pp. 1272- 1275 ,(1994) , 10.1056/NEJM199405053301804

Greg Brown, John J. Albers, Lloyd D. Fisher, Susan M. Schaefer, Jiin-Tarng Lin, Cheryl Kaplan, Xue-Qiao Zhao, Brad D. Bisson, Virginia F. Fitzpatrick, Harold T. Dodge, Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B The New England Journal of Medicine. ,vol. 323, pp. 1289- 1298 ,(1990) , 10.1056/NEJM199011083231901

Hanna Bloomfield Rubins, Sander J. Robins, Dorothea Collins, Carol L. Fye, James W. Anderson, Marshall B. Elam, Fred H. Faas, Esteban Linares, Ernst J. Schaefer, Gordon Schectman, Timothy J. Wilt, Janet Wittes, Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol The New England Journal of Medicine. ,vol. 341, pp. 410- 418 ,(1999) , 10.1056/NEJM199908053410604